UB Paderborn / Katalog / Suche / in CDI

The androgen/androgen receptor axis in prostate cancer

Current opinion in oncology, 2012-05, Vol.24 (3), p.251-257

2012

Volltextzugriff (PDF)

Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling

Cancer cell, 2017-10, Vol.32 (4), p.474-489.e6

2017

Volltextzugriff (PDF)

Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer

Cancer research (Chicago, Ill.), 2012-07, Vol.72 (14), p.3457-3462

2012

Volltextzugriff (PDF)

The androgen/androgen receptor axis in prostate cancer

Current opinion in oncology, 2012-05, Vol.24 (3), p.251-257

2012

Volltextzugriff (PDF)

Endovascular-First Treatment of Peripheral Arterial Disease Remains Controversial

Journal of the American College of Cardiology, 2016-09, Vol.68 (13), p.1492-1492

2016

Volltextzugriff (PDF)

Acute Limb Ischemia in a 26-Year-Old Man Presenting with an Idiopathic Thrombosed Popliteal Artery Aneurysm

Annals of vascular surgery, 2020-01, Vol.62, p.498.e7-498.e10

2020

Volltextzugriff (PDF)

PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortality

Molecular cancer research, 2013-06, Vol.11 (6), p.568-578

2013

Volltextzugriff (PDF)

Analysis of Thirty-Day Readmission after Infrainguinal Bypass

Annals of vascular surgery, 2019-11, Vol.61, p.34-47

2019

Volltextzugriff (PDF)

Sequential aneurysms of the internal carotid artery with fibromuscular dysplasia

Journal of vascular surgery, 2018-10, Vol.68 (4), p.1226-1227

2018

Volltextzugriff (PDF)

NESVS12. Analysis of 30-Day Readmission After Infrainguinal Bypass: Lessons Learned from a Trial of 30-Day Data Collection in the Vascular Study Group of New England

Journal of vascular surgery, 2018-10, Vol.68 (4), p.e103-e103

2018

Volltextzugriff (PDF)

Abstract IA21: AR is ablated: Now what? Targeting the double-negative phenotype

Cancer research (Chicago, Ill.), 2018-08, Vol.78 (16_Supplement), p.IA21-IA21

2018

Volltextzugriff (PDF)

Abstract B11: Loss of the androgen receptor (AR) ligand-binding domain transforms the AR transcriptome in prostate cancer

Cancer research (Chicago, Ill.), 2012-02, Vol.72 (4_Supplement), p.B11-B11

2012

Volltextzugriff (PDF)

Abstract A25: Genome-wide methylation analyses in advanced-stage prostate cancer models

Cancer research (Chicago, Ill.), 2012-02, Vol.72 (4_Supplement), p.A25-A25

2012

Volltextzugriff (PDF)

Association of decreased expression of protein phosphatase 2A subunit PR55γ (PPP2R2C) with an increased risk of metastases and prostate cancer-specific mortality

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.4669-4669

2012

Volltextzugriff (PDF)

Abstract IA21: Transcriptional programs directed by the androgen receptor splice variants

Cancer research (Chicago, Ill.), 2012-02, Vol.72 (4_Supplement), p.IA21-IA21

2012

Volltextzugriff (PDF)

Bypassing androgen pathway dependence in advanced prostate cancer

Bluemn, Eric Gregory

2012

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The androgen/androgen receptor axis in prostate cancer

Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling

Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer

The androgen/androgen receptor axis in prostate cancer

Endovascular-First Treatment of Peripheral Arterial Disease Remains Controversial

Acute Limb Ischemia in a 26-Year-Old Man Presenting with an Idiopathic Thrombosed Popliteal Artery Aneurysm

PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortality

Analysis of Thirty-Day Readmission after Infrainguinal Bypass

Sequential aneurysms of the internal carotid artery with fibromuscular dysplasia

NESVS12. Analysis of 30-Day Readmission After Infrainguinal Bypass: Lessons Learned from a Trial of 30-Day Data Collection in the Vascular Study Group of New England

Abstract IA21: AR is ablated: Now what? Targeting the double-negative phenotype

Abstract B11: Loss of the androgen receptor (AR) ligand-binding domain transforms the AR transcriptome in prostate cancer

Abstract A25: Genome-wide methylation analyses in advanced-stage prostate cancer models

Association of decreased expression of protein phosphatase 2A subunit PR55γ (PPP2R2C) with an increased risk of metastases and prostate cancer-specific mortality

Abstract IA21: Transcriptional programs directed by the androgen receptor splice variants

Bypassing androgen pathway dependence in advanced prostate cancer

Suchergebnisse filtern